Cite
HARVARD Citation
Busse, W. et al. (n.d.). S31 Dupilumab reduces severe exacerbations across baseline disease characteristics in patients with elevated baseline type 2 biomarkers: the LIBERTY ASTHMA QUEST study. Thorax. pp. A21-A22. [Online].